Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 4, 2010, Pages 595-601

  Wu, Jin Cai ^a,b   Sun, Bing Sheng ^a,c   Ren, Ning ^a   Ye, Qing Hai ^a   Qin, Lun Xiu ^a  

^a FUDAN UNIVERSITY   (China)

^b YIWU CENTRAL HOSPITAL   (China)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Array CGH; Chromosomal aberration; Hepatocellular carcinoma; Immunohistochemistry; Metastasis; Osteopontin; Tumor heterogeneity

Indexed keywords

GENOMIC DNA; OSTEOPONTIN;

ARTICLE; BILE DUCT; BLOOD VESSEL; CANCER CELL; CANCER INVASION; CANCER TISSUE; CHROMOSOME 13Q; CHROMOSOME 4Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; ONCOGENE; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN;

EID: 77949271489     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0695-0     Document Type: Article

References (35)

1. D Agrawal T Chen R Irby J Quackenbush AF Chambers M Szabo A Cantor D Coppola TJ Yeatman 2002 Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 513 521 1:CAS:528:DC%2BD38Xjt1Ciurw%3D 11929952
2. D Agrawal T Chen R Irby J Quackenbush AF Chambers M Szabo A Cantor D Coppola TJ Yeatman 2003 Osteopontin identified as colon cancer tumor progression marker C R Biol 326 1041 1043 10.1016/j.crvi.2003.09.007 10.1016/j.crvi.2003. 09.007 1:CAS:528:DC%2BD3sXps1Oms7s%3D 14744111 (Pubitemid 38016459)
3. EV Ariztia V Subbarao DB Solt AW Rademaker AP Iyer ZN Oltvai 2003 Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation Exp Cell Res 288 257 267 10.1016/S0014-4827(03)00118-6 10.1016/S0014-4827(03)00118-6 1:CAS:528:DC%2BD3sXmt1ehur4%3D 12915117 (Pubitemid 36959943)
4. TN Campbell S Attwell M Arcellana-Panlilio SM Robbins 2006 Ephrin A5 expression promotes invasion and transformation of murine fibroblasts Biochem Biophys Res Commun 350 623 628 10.1016/j.bbrc.2006.09.085 10.1016/j.bbrc.2006. 09.085 1:CAS:528:DC%2BD28XhtVyisbjM 17022942 (Pubitemid 44547894)
5. G Carlinfante D Vassiliou O Svensson M Wendel D Heinegård G Andersson 2003 Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma Clin Exp Metastasis 20 437 444 10.1023/A:1025419708343 10.1023/A:1025419708343 1:CAS:528:DC%2BD3sXot1Wjurs%3D 14524533 (Pubitemid 37108430)
6. M Chaplet D Waltregny C Detry LW Fisher V Castronovo A Bellahcene 2006 Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness Int J Cancer 118 850 856 10.1002/ijc.21442 10.1002/ijc.21442 1:CAS:528:DC%2BD28Xhtlaisro%3D 16108038 (Pubitemid 43157660)
7. H Chen Y Ke AJ Oates R Barraclough PS Rudland 1997 Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line Oncogene 14 1581 1588 10.1038/sj.onc.1200993 10.1038/sj.onc.1200993 1:CAS:528:DyaK2sXislKls70%3D 9129149
8. ST Cheung KL Leung YC Ip X Chen DY Fong IO Ng ST Fan S So 2005 Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma Clin Cancer Res 11 551 556 1:CAS:528:DC%2BD2MXislWgtL4%3D 15701840
9. D Coppola M Szabo D Boulware P Muraca M Alsarraj AF Chambers TJ Yeatman 2004 Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res 10 184 190 10.1158/1078-0432.CCR-1405-2 10.1158/1078-0432.CCR-1405-2 1:CAS:528: DC%2BD2cXkvF2msg%3D%3D 14734468 (Pubitemid 38114178)
10. DT Denhardt M Noda 1998 Osteopontin expression and function: role in bone remodeling J Cell Biochem Suppl 30-31 92 102 10.1002/(SICI)1097-4644(1998)72: 30/31+<92::AID-JCB13>3.0.CO;2-A 10.1002/(SICI)1097-4644(1998)72:30/ 31+<92::AID-JCB13>3.0.CO;2-A 9893260
11. DT Denhardt M Noda AW O'Regan D Pavlin JS Berman 2001 Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 1055 1061 10.1172/JCI12980 10.1172/JCI12980 1:CAS:528:DC%2BD3MXjsVCjtL0%3D 11342566
12. M Gotoh M Sakamoto K Kanetaka M Chuuma S Hirohashi 2002 Overexpression of osteopontin in hepatocellular carcinoma Pathol Int 52 19 24 10.1046/j.1440-1827.2002.01316.x 10.1046/j.1440-1827.2002.01316.x 1:CAS:528:DC%2BD38XislKqtLc%3D 11940202 (Pubitemid 34299209)
13. NI Herath MD Spanevello S Sabesan T Newton M Cummings S Duffy D Lincoln G Boyle PG Parsons AW Boyd 2006 Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival BMC Cancer 6 144 10.1186/1471-2407-6-144 10.1186/1471-2407-6-144 16737551 (Pubitemid 44057312)
14. J Huang HH Sheng T Shen YJ Hu HS Xiao Q Zhang QH Zhang ZG Han 2006 Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma FEBS Lett 580 3571 3581 10.1016/j.febslet.2006.05.032 10.1016/j.febslet.2006.05.032 1:CAS:528:DC%2BD28XmtVOmsbo%3D 16750200 (Pubitemid 43902791)
15. AC Khodavirdi Z Song S Yang C Zhong S Wang H Wu C Pritchard PS Nelson P Roy-Burman 2006 Increased expression of osteopontin contributes to the progression of prostate cancer Cancer Res 66 883 888 10.1158/0008-5472.CAN-05- 2816 10.1158/0008-5472.CAN-05-2816 1:CAS:528:DC%2BD28XlsFOqsw%3D%3D 16424021 (Pubitemid 43165954)
16. J Kim SS Ki SD Lee CJ Han YC Kim SH Park SY Cho YJ Hong HY Park M Lee HH Jung KH Lee SH Jeong 2006 Elevated plasma osteopontin levels in patients with hepatocellular carcinoma Am J Gastroenterol 101 2051 2059 10.1111/j.1572-0241. 2006.00679.x 10.1111/j.1572-0241.2006.00679.x 1:CAS:528:DC%2BD28XhtVyisLzI 16848813 (Pubitemid 44337631)
17. M Kinjo T Okegawa S Horie K Nutahara E Higashihara 2004 Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients Int J Urol 11 38 43 10.1111/j.1442-2042. 2004.00739.x 10.1111/j.1442-2042.2004.00739.x 1:CAS:528:DC%2BD2cXhsVOqsbg%3D 14678183 (Pubitemid 38134702)
18. J Koopmann NS Fedarko A Jain A Maitra C Iacobuzio-Donahue A Rahman RH Hruban CJ Yeo M Goggins 2004 Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev 13 487 491 1:CAS:528:DC%2BD2cXhvVygtL4%3D 15006928
19. F Liang J Liang WQ Wang JP Sun E Udho ZY Zhang 2007 PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation J Biol Chem 282 5413 5419 10.1074/jbc.M608940200 10.1074/jbc.M608940200 1:CAS:528:DC%2BD2sXhvVaju7Y%3D 17192274 (Pubitemid 47093772)
20. AJ Oates R Barraclough PS Rudland 1996 The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model Oncogene 13 97 104 1:CAS:528:DyaK28Xks1ens7g%3D 8700559 (Pubitemid 26248549)
21. AJ Oates R Barraclough PS Rudland 1997 The role of osteopontin in tumorigenesis and metastasis Invasion Metastasis 17 1 15 1:CAS:528: DyaK1cXjsFehsw%3D%3D 9425320
22. HW Pan YH Ou SY Peng SH Liu PL Lai PH Lee JC Sheu CL Chen HC Hsu 2003 Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer 98 119 127 10.1002/cncr.11487 10.1002/cncr.11487 1:CAS:528: DC%2BD3sXlslagur4%3D 12833464 (Pubitemid 36741134)
23. M Retz J Lehmann C Szysnik S Zwank T Venzke C Röder H Kalthoff C Basbaum M Stöckle 2004 Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR Eur Urol 45 314 319 10.1016/j.eururo.2003.10.011 10.1016/j.eururo.2003.10.011 1:CAS:528: DC%2BD2cXisVWmtbg%3D 15036676 (Pubitemid 38221404)
24. SR Rittling AF Chambers 2004 Role of osteopontin in tumour progression Br J Cancer 90 1877 1881 10.1038/sj.bjc.6601839 10.1038/sj.bjc.6601839 1:CAS:528:DC%2BD2cXjvVals7g%3D 15138464 (Pubitemid 38746324)
25. PS Rudland A Platt-Higgins M El-Tanani S De Silva Rudland R Barraclough JH Winstanley R Howitt CR West 2002 Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res 62 3417 3427 1:CAS:528:DC%2BD38XkslWqsb0%3D 12067984
26. Y Saeki T Mima T Ishii A Ogata H Kobayashi S Ohshima T Ishida Y Tabunoki H Kitayama M Mizuki Y Katada H Asaoku M Kitano N Nishimoto K Yoshizaki M Maeda S Kon N Kinoshita T Uede I Kawase 2003 Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications Br J Haematol 123 263 270 10.1046/j.1365-2141.2003.04589.x 10.1046/j.1365-2141.2003.04589.x 1:CAS:528:DC%2BD3sXptFKrs7c%3D 14531907 (Pubitemid 37305060)
27. R Sedivy K Peters G Kloppel 2005 Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas Virchows Arch 446 41 45 10.1007/s00428-004-1142-x 10.1007/s00428-004-1142-x 1:CAS:528:DC%2BD2MXltVWlsA%3D%3D 15568158 (Pubitemid 40179155)
28. DR Senger CA Perruzzi 1996 Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin Biochim Biophys Acta 1314 13 24 10.1016/S0167-4889(96)00067-5 10.1016/S0167-4889(96)00067-5 1:CAS:528:DyaK28XmvFaksrg%3D 8972713 (Pubitemid 26395494)
29. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11(3):259-273
30. Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX (2008) Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology [Epub ahead of print]
31. GN Thalmann RA Sikes RE Devoll JA Kiefer R Markwalder I Klima CM Farach-Carson UE Studer LW Chung 1999 Osteopontin: possible role in prostate cancer progression Clin Cancer Res 5 2271 2277 1:CAS:528:DyaK1MXlvVOgsrs%3D 10473115
32. AB Tuck DM Arsenault FP O'Malley C Hota MC Ling SM Wilson AF Chambers 1999 Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene 18 4237 4246 10.1038/sj.onc.1202799 10.1038/sj.onc.1202799 1:CAS:528:DyaK1MXlt1OlsLs%3D 10435636 (Pubitemid 29377854)
33. X Wang M Fan X Chen S Wang MJ Alsharif L Wang L Liu H Deng 2006 Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma Oral Oncol 42 740 744 10.1016/j.oraloncology.2005. 11.018 10.1016/j.oraloncology.2005.11.018 1:CAS:528:DC%2BD28XntlGiurY%3D 16455286 (Pubitemid 44094241)
34. QH Ye LX Qin M Forgues P He JW Kim AC Peng R Simon Y Li AI Robles Y Chen ZC Ma ZQ Wu SL Ye YK Liu ZY Tang XW Wang 2003 Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 416 423 10.1038/nm843 10.1038/nm843 1:CAS:528:DC%2BD3sXisVOmu7o%3D 12640447 (Pubitemid 36460075)
35. H Zhang QH Ye N Ren L Zhao YF Wang X Wu HC Sun L Wang BH Zhang YK Liu ZY Tang LX Qin 2006 The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma J Cancer Res Clin Oncol 132 709 717 10.1007/s00432-006-0119-3 10.1007/s00432-006-0119-3 1:CAS:528:DC%2BD28XptVajs78%3D 16786357 (Pubitemid 44337931)